Tag: iShares U.S. Pharmaceuticals ETF

Eli Lilly says next-generation weight loss drug clears crucial obesity trial

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Eli Lilly opposes push to pass Trump’s drug pricing deals into law, CEO says

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders